ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
8,91
-0,09
(-1,00%)
Geschlossen 27 Juni 5:30PM

Guerbet SA (GBT) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
8,91
( -1,00% )
Gebot
8,83
Fragen
9,00
Volumen
44.462
8,79 Tagesbereich 9,00
8,01 52-Wochen-Bereich 23,10
Marktkapitalisierung
Handelsende
9,00
Handelsbeginn
8,99
Letzte Trade
5
@
8.91
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
15.188 €
Ausgegebene Aktien
12.615.123
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1,07
Gewinn pro Aktie (EPS)
-8,59
Erlöse (LTM)
798,67M
Nettogewinn (LTM)
-108,33M

Über Guerbet SA

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based c... Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconnected solution; and Artirem, a gadoteric acid. The company also provides OptiStar Elite, a dual head contrast delivery system with an ultrasonic motor; Ready-Box, a contrast media warmer; MRI accessories and consumables for diagnostic imaging; OptiProtect 3S, a suite of services and support solution; Conray/Cysto-Conray, an iothalamate meglumine injection contrast agent for CT; Micropaque/Microtrast, a barium sulfate contrast agent for CT; Optiray, an ioversol contrast agent for CT and Cath lab; Telebrix Gastro, a meglumine ioxitalamate contrast agent for CT; and Xenetix/ScanBag by Xenetix, an Iobitridol contrast agent for CT and Cath lab. In addition, it offers OptiBolus, which allows for a uniform vascular enhancement throughout the procedure; OptiOne, a single head injector; OptiVantage Multi-use, an optimal power injector for X-ray procedures; OptiVantage, a dual-head CT contrast delivery injector; Illumena Néo, a multi-mode contrast delivery injector; Lipiodol Ultra Fluid, an iodinated ethyl ester of fatty acids of poppy seed oil; Qitexio, a range of lipiodol resistant medical devices consisting of medical syringes and a stopcock; Lipiodol Ultra Fluid for use in interventional radiology and women’s health; and Patent Blue V, a pharmaceutical drug for breast cancer. The company was founded in 1901 and is headquartered in Villepinte, France. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Website
Hauptsitz
Villepinte, France
Gegründet
2026
Guerbet SA is listed in the Healthcare sector of the Euronext with ticker GBT. The last closing price for Guerbet was 9,00 €. Over the last year, Guerbet shares have traded in a share price range of 8,01 € to 23,10 €.

Guerbet currently has 12.615.123 shares in issue. The market capitalisation of Guerbet is 112,40 € million. Guerbet has a price to earnings ratio (PE ratio) of -1.07.

GBT Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.49-5.212765957459.49.458.73215189.08939603DE
4-1.57-14.980916030510.4810.928.73133199.7792814DE
12-0.63-6.603773584919.5412.668.641488610.06499105DE
26-5.29-37.253521126814.215.128.011444610.7350045DE
52-11.64-56.642335766420.5523.18.011833813.22586248DE
156-7.79-46.646706586816.740.258.011548721.86924096DE
260-22.59-71.714285714331.544.48.011451122.28953906DE

GBT - Frequently Asked Questions (FAQ)

What is the current Guerbet SA share price?
The current share price of Guerbet SA is 8,91 €
How many Guerbet SA shares are in issue?
Guerbet SA has 12.615.123 shares in issue
What is the market cap of Guerbet SA?
The market capitalisation of Guerbet SA is EUR 112,4M
What is the 1 year trading range for Guerbet SA share price?
Guerbet SA has traded in the range of 8,01 € to 23,10 € during the past year
What is the PE ratio of Guerbet SA?
The price to earnings ratio of Guerbet SA is -1,07
What is the cash to sales ratio of Guerbet SA?
The cash to sales ratio of Guerbet SA is 0,15
What is the registered address of Guerbet SA?
The registered address for Guerbet SA is 15 rue des Vanesses, Villepinte, Ile-de-France, 93420
What is the Guerbet SA website address?
The website address for Guerbet SA is www.guerbet.com
Which industry sector does Guerbet SA operate in?
Guerbet SA operates in the Medical Equipment & Supplies sector

GBT Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock